MassGeneral Institute for Neurodegenerative Disease

Charlestown, Massachusetts 02129

0 studies enrolling now · 1 studies all time

What they study most

Alzheimer Disease

Studies at this site

• Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease — Completed